Author Correction: α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice

Files
41401_2021_Article_802.pdf (2.05 MB)
If you need an accessible version of this item, please submit a remediation request.
Date
2022
Authors
Chen, Xin
Liu, Jie
Liu, Jie
Wang, Wen-Jia
Lai, Wen-Jing
Li, Shu-Hui
Deng, Ya-Fei
Zhou, Jian-Zhi
Yang, Sheng-Qian
Liu, Ying
Shou, Wei-Nian
Cao, Da-Yan
Li, Xiao-Hui
Language
American English
Embargo Lift Date
Department
Pediatrics, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Springer Nature
Abstract

This corrects the article "α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice" in volume 41 on page 1416.

Description
Keywords
α-galactosylceramide, OCH, iNKT cells, Isoproterenol, Cancer immunotherapy, Cardiotoxicity, Oncocardiology
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Chen X, Liu J, Liu J, et al. Author Correction: α-Galactosylceramide and its analog OCH differentially affect the pathogenesis of ISO-induced cardiac injury in mice. Acta Pharmacol Sin. 2022;43(7):1875-1878. doi:10.1038/s41401-021-00802-5
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Acta Pharmacologica Sinica
Rights
Publisher Policy
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/34666
DOI
https://doi.org/10.1038/s41401-021-00802-5
Version
Final published version
Full Text Available at
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253304/
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Pediatrics Works